Other ADCs are giving early promising results in PDX models, such as immunoconjugates linked to the cytotoxic payload amanitin and directed against CD37, an antigen expressed on the cellular membrane of DLBCL-type RS cells [115]. This evidence concerns the gene CD37 and diffuse large B-cell lymphoma.